Characterization of women with a history of recurrent vulvovaginal candidosis.
Recurrent vulvovaginal candidosis (RVVC) is a common condition considered to affect 5-8% of all women, most often during reproductive age (1) . Only in a small percentage of all RVVC cases, factors that have been associated with the condition, such as broad-spectrum antibiotic therapy, contraceptive use, pregnancy and uncontrolled diabetes mellitus, can be demonstrated (2) . There have been a variety of proposals that one or more other factors can influence the rate of RVVC in a female population (3, 4) , but they have generally remained scientifically unproven (2) . C Acta Obstet Gynecol Scand 81 (2002) The diagnosis of attacks of RVVC in routine health care is often false (3) , even if based on extensive history taking and clinical findings. Thus, in only approximately half or less of such cases, Candida can be recovered from the genital tract (5, 6) . Eckert and co-workers (7) could only identify Candida in vaginal cultures in 28% of 554 women with symptoms regarded consistent with 'Candida vaginitis'.
The present investigation was undertaken to study in which respects, if any, women with a history of RVVC and who had current symptoms consistent with vulvovaginal candidosis (VVC), and who proved positive for Candida from the genital tract, differed from those who were culturenegative for such yeasts. A comparison was also made with a cohort without any history of VVC/ RVVC or any such current problems. Extensive history taking, a pelvic examination and microbiological tests for Candida were performed. We also discuss the occurrence of some factors in our patients that have been regarded to trigger attacks of RVVC.
Materials and methods

Women with a history of RVVC
The 83 women studied had attended the outpatient department of the University maternity hospital No. 3, Kiev, Ukraine, from October 2000 to May 2001, because of current genital symptoms suggestive of VVC The patients enrolled in the study had either been referred to the investigators by other gynecologists in the city or had consulted directly at the clinic. They had all a history assuming that they had had at least four attacks of VVC during the last year, i.e. they fulfilled the criteria for RVVC (2) . The age range of the women studied was 17-42 years. The study group was divided into those who were Candida culture-positive (43 cases) and Candida culture-negative (40 cases) from the genital tract. The mean age of women of the Candida culture-positive and culture-negative group was 26.1 and 25.3 years, respectively.
The women enrolled in the study had given written consent for their participation. The study was approved by the institutional review board.
History taking
The women were asked for current symptoms and examined for any pathological genital signs; in all 16 parameters were noted. A structured interview, in all covering 32 possible etiological factors of RVVC, was performed. The patients had at least once, but generally several times, presented with a vaginal smear showing Candida morphotypes, i.e. blastoconidia and/or pseudohyphae.
Sampling and laboratory tests
Samples from the introitus and the posterior vaginal fornix were collected and cultured on Sabouraud (Beckton DickinsonA, Baltimore, Maryland USA) and chromogenic agar (CHROMagar, Paris, France). Indicator sticks measured the pH of vaginal secretions (Merck KGaA, Darmstadt, Germany).
Women without any history or current symptoms suggestive of VVC/RVVC
A group of 136 women without any history or any current complaints suggesting either VVC or C Acta Obstet Gynecol Scand 81 (2002) RVVC were interviewed using the same questionnaire as in the above-mentioned women with a history of RVVC No gynecologic examination or laboratory tests were made in this group of women. The age range in this cohort was also 17-42 years (mean age 25.2 years).
Statistics
Data were analyzed by means of the SPSS (LDC, Lund) 10.0 statistical software, and the c 2 and Fisher's exact test. A p-value Ͻ0.05 was considered significant. Table I shows anamnestic data in the two groups of symptomatic patients with and without a confirmed genital Candida infection and in the healthy comparison group. Women with RVVC reported a history of gynecologic diseases more frequently than women in the healthy comparison group. Table II shows the history in the two symptomatic groups. Only two factors differed between the groups, namely yogurt intake, which was reported by 28 (68%) and 38 (95%) women in these groups, respectively. Vaginal douching was performed by 10 (23%) women in the Candida-positive group and by 17 (42%) women in the Candidanegative group. The corresponding figures in the comparison group of healthy women were 128 (94%) and 17 (12%), respectively.
Results
History
Parameters concerning partner relations and contraception use in the three study groups are shown in Table III . In those with a positive yeast culture, intercourse for the first time had taken place at a mean of 4.5 years (range 0.5-17) before enrollment in the study. In the culture-negative group, the corresponding figure was 3.6 years (range 0.5-17) ago.
When asked whether the patients believed that the onset of their 'RVVC problems' had occurred in conjunction with any specific event, the following most frequent answers were obtained: during or shortly after a course of antibiotic therapy (7 cases), during pregnancy (4 cases), and shortly after having intercourse for the first time (4 cases). The corresponding figures in the culture-negative group were four, seven, and four, respectively. Only single patients in each of the groups believed that their problems started after an experience of severe stress or during a period of particularly warm or humid weather. Also, other uncommon proposals were onset after wearing too tight clothes, after iatrogenic measures or because they had suffered from a hormonal disorder. Twenty-six of the Candida culture-positive (50?) and 22 (55%) of the culture-negative patients could not associate the onset of RVVC to any specific event.
Symptoms
Itching, an irritating feeling in the vulva and dysuria, occurred significantly more often in those with than without a positive Candida culture (Table IV) . Otherwise, there were no statistical differences between the patients with regard to the symptoms registered.
Signs
The amount and the color of the vaginal discharge in the two groups with different culture results did not differ (p Ͼ 0.05), although a caseous discharge was more common in the culture-positive group (p Ω 0.016) ( Table V) . Edema of the vulva (p Ω 0.026), erythema (p Ω 0.019) and edema (p Ω 0.008) C Acta Obstet Gynecol Scand 81 (2002) of the vaginal mucosa were, however, more common in the culture-positive group (Table VI) .
Discussion
Obviously, there is an age-related physiological influence of sex hormones on the prevalence of RVVC, including the hormonal changes occurring during pregnancy (8) .
However, in only 6% of our cases, first onset of symptoms suggestive of an attack of VVC had occurred during pregnancy. RVVC is uncommon before menarche and less common after than before menopause, although an increased prevalence is seen in women given hormone replacement therapy. The period in life we choose to study represented most of the reproductive age, i.e. we enrolled women 17-42 years of age.
Early start of sexual life has been regarded as a predisposing factor for RVVC (9) . However, the mean age for first intercourse in our Candida culture-positive group (18. 1 years) did not differ from that of the culture-negative women (18. 8 years). Neither did it differ from the mean age (19.3 years) in the healthy comparison group.
Use of high estrogen-containing oral contraceptives has by some authors been found to trigger attacks of RVVC (10,11), while others have not found colonization by Candida to be more common in such users than non-users (12) . In the present study, only a few used 'the pill', i.e. five (12%) of the culture-positive and only one (2.5%) of the culture-negative women. Spermicides were not used by more than one patient in each of the two groups from which Candida cultures had been made. None utilized a diaphragm, which is still another contraceptive method that has been associated with RVVC (13) (14) (15) . A number of other behavior-related factors have been assumed, but hardly proven to trigger RVVC (2) . These factors include a high frequency of intercourse and multiple partners as well as oral and anal sex (9, 13, 17, 18) . However, we did not find such sexual practice to differ between the women in our study who were and were not found to harbor Candida (19) . Unproven triggering factors of RVVC include wearing of tight-fitting clothes and of synthetic underwear (12) and wearing underwear washed at a temperature unable to kill Candida organisms (20) . Certain hygiene procedures have also been considered to be associated with genital Candida infections, including vaginal douching. The latter was a significantly more common practice (with water) among our Candida culture-negative than culture-positive women (Table  II) .
There is firm evidence that poor glucemic control in diabetes mellitus patients can trigger RVVC attacks (21) . Goswami and co-authors (22) found a higher prevalence rate of VVC in diabetic women (46%) than in healthy controls (23%) (p Ω 0.025). None of our patients had, however, diabetes mellitus. Overweight is associated with diabetes and with Candida skin infections (2) . Only one of our patients with a history of RVVC was obese. Intake of rapid carbohydrates is believed to be able to induce new attacks of RVVC (21, 22) . However, available data are inconsistent regarding the impact of certain diets on RVVC (2) .
There are a number of hypotheses that immune pathogenetic mechanisms can explain RVVC, e.g. inability of the cell-mediated immune system to effectively limit growth of Candida (23) . The current study did not, however, allow valuation of the importance of an immune dysfunction in our patients, but the severely impaired cellular immunity in advanced AIDS cases is associated with both general and vaginal Candida infections.
VVC/RVVC are not useful early markers of HIV infection (24); HIV-infections had not been diagnosed in any of our patients.
Recurrences of VVC have been blamed on therapeutic failure due to antifungal resistance (25) . Recently, we described a new resistance mechanism in one of the drugs often used to treat RVVC cases, i.e. fluconazole. There is an efflux of the drug in fluconazole-resistant Candida strains (26) . However, in our study population fluconazole had only been used by a few of our patients.
The high rate, e.g. 52%, of negative Candida cultures in our patients with a history of RVVC, and who had symptoms and signs that could have sug-C Acta Obstet Gynecol Scand 81 (2002) gested that they had a current genital infection, points to the difficulty in identifying 'true' RVVC cases. That is, to track down such 'RVVC' patients, who really have a genital infection by Candida. The use of yeast culture and patient-close diagnostic tests for the detection of Candida cell morphotypes, i.e. of blastoconidia and/or pseudohyphae, in wet mount or stained vaginal and/or introital smears [as we have reported elsewhere (16) ], may also help to identify Candida-infected persons. Thus, it is essential to stress that a microbiologic diagnosis is necessary to identify those cases that have a Candida infection that one generally associated with the condition among patients with a history of RVVC and who consult with symptoms and signs. Episodes believed to represent RVVC must be classified as 'idiopathic' cases, as factors that have been associated with RVVC can only be demonstrated in a minority of them.
